{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:08:16Z","timestamp":1778818096163,"version":"3.51.4"},"reference-count":70,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T00:00:00Z","timestamp":1501718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Laryngoscope"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>To investigate the potential association of macrolide antibiotics with sensorineural hearing loss (SNHL) and which agents and dosage may be related. To evaluate whether an optimal treatment exists for reversing SNHL that occurs after macrolide therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study Design<\/jats:title><jats:p>Systematic review of the literature.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Computerized (PubMed, EMBASE, Cochrane Library) and manual searches were performed to identify human studies of all ages (patients) who received macrolides (intervention, with or without control) and documented SNHL (outcome). All study designs were assessed. Extracted data included macrolide regimen details, as well as the timing, severity, and reversibility of SNHL with drug cessation alone or with additional medical intervention. Study designs and the associated risk of bias were assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The 44 publications (3 prospective, 41 retrospective) that met these criteria described 78 cases of audiometrically confirmed SNHL. SNHL was associated with oral and intravenous macrolide administration at standard and elevated doses. SNHL was irreversible in six cases, despite macrolide cessation (n = 5) and oral steroid treatment (n = 1). Irreversible SNHL was observed following 2 to 3 days of exposure. SNHL was reversible with macrolide cessation alone in 70 cases. In two cases, macrolide cessation coupled with oral steroid administration restored hearing. Reversible cases improved within hours to days. Nine studies also described 42 cases of subjective patient\u2010reported hearing loss. Limitations in the data arose from study design, related comorbidities, and concomitant drug administration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>SNHL may follow macrolide exposure, even at standard oral doses. Further research is needed to understand the incidence, prevalence, and biological mechanism of its ototoxicity.<jats:italic>Laryngoscope<\/jats:italic>, 128:228\u2013236, 2018<\/jats:p><\/jats:sec>","DOI":"10.1002\/lary.26799","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T19:39:07Z","timestamp":1501789147000},"page":"228-236","source":"Crossref","is-referenced-by-count":49,"title":["Macrolide\u2010associated sensorineural hearing loss: A systematic review"],"prefix":"10.1002","volume":"128","author":[{"given":"Allison K.","family":"Ikeda","sequence":"first","affiliation":[{"name":"School of Medicine Emory University Atlanta Georgia U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony A.","family":"Prince","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Harvard Medical School Boston Massachusetts U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny X.","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Harvard Medical School Boston Massachusetts U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith E. C.","family":"Lieu","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Washington University St. Louis Missouri U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer J.","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Harvard Medical School Boston Massachusetts U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,8,3]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1124"},{"key":"e_1_2_7_3_1","first-page":"1150","article-title":"Hearing loss in older adults","volume":"85","author":"Walling AD","year":"2012","journal-title":"Am Fam Physician"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119616"},{"issue":"1","key":"e_1_2_7_5_1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000380746","article-title":"Quality of life and auditory performance in adults with asymmetric hearing loss","volume":"20","author":"Vannson N","year":"2015","journal-title":"Audiol Neurootol"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S26059"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/43.5.661"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0802129"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1017\/S002221511300306X"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/0194599814553930"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00129492-200407000-00025"},{"key":"e_1_2_7_12_1","volume-title":"Uptodate","author":"Grazani A","year":"2015"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2009.06.013"},{"key":"e_1_2_7_14_1","volume-title":"Ototoxicity","author":"Roland PS","year":"2004"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1993.00410070063009"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/106002809302700724"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02239-13"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-2869"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.2008"},{"key":"e_1_2_7_20_1","unstructured":"Federal Food and Drug Administration.Federal Food and Drug Administration adverse events database 2017. Available at:http:\/\/www.fdable.com\/basic_query\/aers\/f335766d349be7317bfd738e4e8f782b. Accessed May 19 2017."},{"key":"e_1_2_7_21_1","unstructured":"Australian Government DoH Therapeutic Goods Administration 2017. Available at:http:\/\/apps.tga.gov.au\/PROD\/DAEN\/daen\u2010entry.aspx. Accessed May 19 2017."},{"key":"e_1_2_7_22_1","unstructured":"Vigiaccess.Monitoring WCCfID.2017. Available at:http:\/\/www.vigiaccess.org\/. Accessed May 19 2017."},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.5.958"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/23.5.983"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(92)90016-5"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.1.76"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1177\/000348940111000119"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.2310\/7070.2007.0047"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1177\/000348940010900416"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91030-8"},{"key":"e_1_2_7_31_1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/ajhp\/56.4.380","article-title":"Azithromycin\u2010Induced hearing loss","volume":"56","author":"Lo SH","year":"1999","journal-title":"Am J Health Syst Pharm"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2004.020412"},{"key":"e_1_2_7_33_1","first-page":"127","article-title":"Clarithromycin induced reversible sensorineural hearing loss","volume":"7","author":"Hajiioannou JK","year":"2011","journal-title":"B\u2010ENT"},{"key":"e_1_2_7_34_1","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/bmj.302.6788.1341-c","article-title":"Sensorineural hearing loss with low dose erythromycin","volume":"302","author":"Kemp E","year":"1991","journal-title":"BMJ"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)91961-X"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1177\/000348947708600103"},{"key":"e_1_2_7_37_1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1399-0012.1993.tb00916.x","article-title":"Erythromycin\u2010induced hearing loss in immunosuppressed transplant patients","volume":"7","author":"Sternberg R","year":"1993","journal-title":"Clin Transplant"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)90344-6"},{"key":"e_1_2_7_39_1","first-page":"186","article-title":"Ototoxicity of erythromycin in man: electrophysiologic approach","volume":"14","author":"Sacristan JA","year":"1993","journal-title":"Am J Otol"},{"key":"e_1_2_7_40_1","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/archinte.1986.00360170099016","article-title":"Erythromycin ototoxicity and acute psychotic reaction in cancer patients with hepatic dysfunction","volume":"146","author":"Umstead GS","year":"1986","journal-title":"Arch Intern Med"},{"key":"e_1_2_7_41_1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archinte.1991.00400020124025","article-title":"Ototoxic reaction to erythromycin","volume":"151","author":"Agusti C","year":"1991","journal-title":"Arch Intern Med"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(81)90501-9"},{"key":"e_1_2_7_43_1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/875512259401000408","article-title":"Erythromycin induced ototoxicity: case report","volume":"10","author":"Fayed D","year":"1994","journal-title":"J Pharm Technol"},{"key":"e_1_2_7_44_1","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/archinte.1983.00350060195035","article-title":"Hearing loss and erythromycin pharmacokinetics in a patient receiving hemodialysis","volume":"143","author":"Kroboth PD","year":"1983","journal-title":"Arch Intern Med"},{"key":"e_1_2_7_45_1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/01050398609045952","article-title":"Irreversible ototoxic effect of erythromycin","volume":"15","author":"Levin G","year":"1986","journal-title":"Scand Audiol"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/00129492-200307000-00029"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1982.tb124352.x"},{"key":"e_1_2_7_48_1","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/00007611-199110000-00013","article-title":"Erythromycin ototoxicity: a call to heighten recognition","volume":"84","author":"Whitener CJ","year":"1991","journal-title":"South Med J"},{"key":"e_1_2_7_49_1","first-page":"190","article-title":"Ototoxicity: a contemporary review of aminoglycosides, loop diuretics, acetylsalicylic acid, quinine, erythromycin, and cisplatinum","volume":"6","author":"Koegel L","year":"1985","journal-title":"Am J Otol"},{"key":"e_1_2_7_50_1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/22953337.1979.11718674","article-title":"Ototoxicity of erythromycin lactobionate","volume":"34","author":"Lornoy W","year":"1979","journal-title":"Acta Clin Belg"},{"key":"e_1_2_7_51_1","first-page":"230","article-title":"Irreversible sensorineural hearing loss due to erythromycin","volume":"139","author":"Dylewski J","year":"1988","journal-title":"CMAJ"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197910253011716"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1177\/019459988409200615"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.225.9.1122"},{"key":"e_1_2_7_55_1","first-page":"935","article-title":"Ototoxicity of erythromycin in peritoneal dialysis patients","volume":"2","author":"Taylor R","year":"1981","journal-title":"Lancet"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1984.00800300050011"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197503202921224"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.309.6969.1620c"},{"key":"e_1_2_7_59_1","first-page":"60","article-title":"Erythromycin ototoxicity","volume":"9","author":"Thompson P","year":"1980","journal-title":"J Otolaryngol"},{"key":"e_1_2_7_60_1","first-page":"374","article-title":"Erythromycin\u2010induced ototoxicity substantiated by rechallenge","volume":"1","author":"Schwartz JI","year":"1982","journal-title":"Clin Pharm"},{"key":"e_1_2_7_61_1","first-page":"821","article-title":"Erythromycin associated hearing loss in a patient with prior cis\u2010platinum induced ototoxicity","volume":"79","author":"Wallach PM","year":"1992","journal-title":"J Fla Med Assoc"},{"key":"e_1_2_7_62_1","first-page":"623","article-title":"Probable erythromycin ototoxicity","volume":"14","author":"Errick JK H\u2010FL","year":"1980","journal-title":"Drug Intell Clin Pharm"},{"key":"e_1_2_7_63_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.19.3.245.30930"},{"key":"e_1_2_7_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.1994.tb01279.x"},{"key":"e_1_2_7_65_1","unstructured":"Uppsala\u2010Monitoring\u2010Centre.World Health Organization Causality Assessment Criteria.2015. Available at:https:\/\/who\u2010umc.org\/. Accessed May 3 2017."},{"key":"e_1_2_7_66_1","doi-asserted-by":"publisher","DOI":"10.1177\/0141076814562718"},{"key":"e_1_2_7_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.26190"},{"key":"e_1_2_7_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-005-2964-3"},{"key":"e_1_2_7_69_1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/00034894840930S420","article-title":"Inner ear and renal diseases","volume":"112","author":"Arnold W","year":"1984","journal-title":"Ann Otol Rhinol Laryngol Suppl"},{"key":"e_1_2_7_70_1","doi-asserted-by":"publisher","DOI":"10.1177\/000348947608500108"},{"key":"e_1_2_7_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)31697-2"}],"container-title":["The Laryngoscope"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flary.26799","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/lary.26799","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T20:23:31Z","timestamp":1750796611000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/lary.26799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,3]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1002\/lary.26799"],"URL":"https:\/\/doi.org\/10.1002\/lary.26799","archive":["Portico"],"relation":{},"ISSN":["0023-852X","1531-4995"],"issn-type":[{"value":"0023-852X","type":"print"},{"value":"1531-4995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,3]]}}}